Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer

This study has been completed.
University of Washington
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center Identifier:
First received: February 26, 2009
Last updated: October 28, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)